Logo

American Heart Association

  2
  0


Final ID: Su4103

Predictors of Flow Improvement Following Transcatheter Aortic Valve Replacement in Patients with Low-Flow Low-Gradient Aortic Stenosis

Abstract Body (Do not enter title and authors here): Background: Patients with low-flow low-gradient (LFLG) aortic stenosis (AS) are at risk of worse outcomes following transcatheter aortic valve replacement (TAVR). Flow is known to improve after TAVR, however the clinical and echocardiographic characteristics correlating with flow improvement in patients with LFLG AS are still unclear.

Hypothesis: Some baseline and discharge clinical and echocardiographic characteristics correlate with flow improvement in patients with LFLG AS post-TAVR.

Aims: The present study sought to explore the clinical and echocardiographic characteristics correlating with flow improvement in patients with LFLG AS post-TAVR.

Methods: This is a retrospective cohort of patients >18 years of age who underwent TAVR at Cleveland Clinic between 2016 and 2020. Only patients with aortic valve (AV) area <1 cm2, AV mean gradient <40 mmHg, and stroke volume index (SVI) <35 mL/m2 were included. Patients were classified into 2 groups according to whether SVI improved by 20% or more at the 30-day follow-up. Patients who underwent valve-in-valve TAVR were excluded. Binary logistic regression was used to evaluate the predictors of flow improvement.

Results: A total of 2630 patients underwent TAVR between 2016 and 2020. The study included 633 patients. 228 patients (36%) had SVI improvement by 20% or more. Male sex (odds ratio (OR)=1.89, p=0.01), left ventricular ejection fraction (LVEF) improvement by 10% or more 1 month post-TAVR (OR=6.93, p<0.001), and lower baseline SVI (OR=0.81, p<0.001), were statistically significant predictors of flow improvement, whereas moderate to severe tricuspid regurgitation (TR) at discharge was a statistically significant predictor of no improvement in flow.

Conclusions: The present study demonstrates that male sex, LVEF improvement post-TAVR, and lower baseline SVI are associated with flow improvement, whereas moderate to severe TR at discharge is associated with no flow improvement post-TAVR in patients with LFLG AS.
  • Besir, Besir  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Reed, Grant  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Puri, Rishi  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Krishnaswamy, Amar  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Kapadia, Samir  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Majeed-saidan, Maryam Muhammad Ali  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Rajendran, Judah  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Lomaia, Tamari  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Kathavarayan Ramu, Shivabalan  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Iskandar, Odette  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Yun, James  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Harb, Serge  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Miyasaka, Rhonda  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Author Disclosures:
    Besir Besir: DO NOT have relevant financial relationships | Grant Reed: DO have relevant financial relationships ; Consultant:Edwards Lifesciences:Active (exists now) ; Advisor:Philips Healthcare:Past (completed) ; Advisor:Boston Scientific:Active (exists now) | Rishi Puri: No Answer | Amar Krishnaswamy: DO NOT have relevant financial relationships | Samir Kapadia: DO NOT have relevant financial relationships | Maryam Muhammad Ali Majeed-Saidan: No Answer | Judah Rajendran: DO NOT have relevant financial relationships | Tamari Lomaia: DO NOT have relevant financial relationships | Shivabalan Kathavarayan Ramu: DO NOT have relevant financial relationships | Odette Iskandar: DO NOT have relevant financial relationships | James Yun: No Answer | Serge Harb: No Answer | Rhonda Miyasaka: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

TAVR Outcomes in Specific Subgroups

Sunday, 11/17/2024 , 03:15PM - 04:15PM

Abstract Poster Session

More abstracts on this topic:
A Meta-Analysis of Prospective Studies Comparing Short and Longterm Outcomes of Trans-Catheter Aortic Valve Replacement in Patient with and without Cancer:

Khan Muhammad Aslam, Haider Adnan, Haider Taimoor, Bhattarai Shraddha, Khan Bilal, Lamichhane Bikal, Shafique Nouman, Rahman Hammad, Aafreen Asna, Muhammad Anza, Bhatia Hitesh, Khan Abid Nawaz Khan, Akbar Usman, Khan Alamzaib

Comparative Outcomes of Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement in Patients with Right Heart Failure: Insights from Nationwide Readmission Database

Kansakar Sajog, Katz Daniel, Shrestha Dhan, Shtembari Jurgen, Sharma Nava, Pant Kailash, Moskovits Norbert, Shetty Vijay, Dahal Khagendra, Mattumpuram Jishanth

More abstracts from these authors:
Clinical Outcomes and Hemodynamic Findings Following Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve in Patients with Small and Non-Small Annulus

Besir Besir, Reed Grant, Puri Rishi, Krishnaswamy Amar, Kapadia Samir, Majeed-saidan Maryam Muhammad Ali, Rajendran Judah, Lomaia Tamari, Kathavarayan Ramu Shivabalan, Iskandar Odette, Yun James, Harb Serge, Miyasaka Rhonda

Neo-Sinus Washout Time Following Transcatheter Aortic Valve Replacement and Hemodynamic Outcomes

Kathavarayan Ramu Shivabalan, Bansal Agam, Abushouk Abdelrahman, Iskandar Odette, Tereshchenko Larisa, Reed Grant, Puri Rishi, Yun James, Harb Serge, Miyasaka Rhonda, Popovic Zoran, Isogai Toshiaki, Krishnaswamy Amar, Kapadia Samir, Beotra Saksham, Kapadia Vishwum, Thakore Nikita, Agrawal Ankit, Shekhar Shashank, Majeed-saidan Maryam Muhammad Ali, Prasad Rohan

You have to be authorized to contact abstract author. Please, Login
Not Available